首页> 外文会议>Conference on quantitative phase imaging >Quantitative phase imaging of platelets in patients with chronic renal failure treated with hemodialysis
【24h】

Quantitative phase imaging of platelets in patients with chronic renal failure treated with hemodialysis

机译:血液透析治疗慢性肾功能衰竭患者血小板的定量相位成像

获取原文

摘要

The development of robust non-invasive laboratory screening methods for early diagnosis on the out-patient basis seems quite relevant for practical medicine. It is known, that platelet is an original biosensor, a detector of early changes in hemostasis condition. The aim of this study was to assess a potential of the quantitative phase imaging (QPI) technique for real time evaluation the influence of low-molecular weight and unfractionated heparin on platelets in patients with the end-stage of chronic renal failure, who were treated with program hemodialysis (PHD). The main group consisted of 21 patients who were administered a low-molecular weight heparin for hypocoagulation during the procedure of hemodialysis. The control group (15 patients) received unfractionated heparin. Morphodensitometric state of living platelets we evaluated by QPI using computer phase-interference microscope MIM (Moscow, Russia). We analyzed the optical-geometrical parameters and the morphological features of living platelets which reflected the degree of their activation at the beginning of PHD (before administration of heparin), in 15 minutes after it and at the end of the procedure. The results allow us to conclude that the use of low-molecular weight heparin provides better ratio of efficacy/safety and causes a reduction of the platelet activation during the hemodialysis procedure. Practical implementation of QPI for clinical monitoring of platelets makes it possible to obtain important information on hemostasis cell. It opens new opportunities to assess the efficacy of treatment, as well as for early diagnosis of complications for disease.
机译:在门诊基础上开发可靠的无创实验室筛查方法以进行早期诊断似乎与实用医学非常相关。众所周知,血小板是原始的生物传感器,是止血状态早期变化的检测器。这项研究的目的是评估定量相成像(QPI)技术用于实时评估低分子量和普通肝素对慢性肾衰竭终末期患者血小板的影响的潜力,这些患者已接受治疗程序性血液透析(PHD)。主要人群包括21例在血液透析过程中接受低分子量肝素低凝治疗的患者。对照组(15名患者)接受普通肝素治疗。我们使用计算机相干显微镜MIM(俄罗斯莫斯科)通过QPI评估了活血小板的形态密度测定状态。我们分析了活体血小板的光学几何参数和形态特征,这些特征反映了它们在PHD开始(肝素给药前),注射后15分钟和手术结束时的活化程度。结果使我们得出结论,使用低分子量肝素可提供更好的功效/安全性比率,并在血液透析过程中降低血小板活化。 QPI在血小板临床监测中的实际应用使获得止血细胞的重要信息成为可能。它为评估治疗效果以及早期诊断疾病并发症提供了新的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号